CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells

• Main Authors: Xiaoxue Jiang (Author), Libo Xing (Author), Yingjie Chen (Author), Rushi Qin (Author), Shuting Song (Author), Yanan Lu (Author), Sijie Xie (Author), Liyan Wang (Author), Hu Pu (Author), Xin Gui (Author), Tianming Li (Author), Jie Xu (Author), Jiao Li (Author), Song Jia (Author), Dongdong Lu (Author)
• Format: Book
• Published: Elsevier, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Circular RNA (CircRNA) is a newly identified special class of non-coding RNA (ncRNA) that plays an important regulatory role in the progression of certain diseases. Herein, our results indicate that CircMEG3 is downregulated expression and negatively correlated with the expression of telomerase-related gene Cbf5 in human liver cancer. Moreover, CircMEG3 inhibits the growth of human liver cancer stem cells in vivo and in vitro. CircMEG3 inhibits the expression of m6A methyltransferase METTL3 dependent on HULC. Moreover, CircMEG3 inhibits the expression of Cbf5, a component of telomere synthetase H/ACA ribonucleoprotein (RNP; catalyst RNA pseudouracil modification) through METTL3 dependent on HULC. Thereby, CircMEG3 inhibits telomerase activity and shortens telomere lifespan dependent on HULC and Cbf5 in human liver cancer stem cell. Strikingly, increased Cbf5 abrogates the ability of CircMEG3 to inhibit malignant differentiation of human liver cancer stem cells. In summary, these observations provide important basic information for finding effective liver cancer therapeutic targets.

Item Description

2162-2531
10.1016/j.omtn.2020.11.009